Biology First.

Asset Centric.

Human Centered Discovery.

Learn More

Our Research

Our Story

Rasayana is harnessing the potential of Gut-Organ Axis biology and novel gut-targeted shelved assets to deliver life-saving drugs to patients as fast as possible.

RSY-248

Our lead asset is a first-in-class, gut-restricted oral biologic

Mission

To discover and deliver transformative medicines for patients as quickly as possible, by targeting the gut and the bidirectional gut-organ biology with gut-targeted molecules.

Gut-Immune-Organ Axes

An Untapped Source for Novel Targets to Treat Chronic Disease

Keep In Touch

We love to meet people who are equally excited about the potential of targeting the Gut-Organ Axes to treat chronic diseases.

Whether you're an investor, biotech professional, student or member of the press, we'd love to hear from you.

Link not working? Email us at vidisha@rasayanatherapeutics.com

Our Company

Email

vidisha@rasayanatherapeutics.com

Headquarters

Cambridge, Massachusetts